China · Delayed Price · Currency is CNY Cisen Pharmaceutical Statistics
Total Valuation
SHA:603367 has a market cap or net worth of CNY 6.85 billion. The enterprise value is 3.53 billion.
| Market Cap | 6.85B |
| Enterprise Value | 3.53B |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603367 has 452.75 million shares outstanding. The number of shares has decreased by -0.31% in one year.
| Current Share Class | 452.75M |
| Shares Outstanding | 452.75M |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | -3.91% |
| Owned by Insiders (%) | 6.50% |
| Owned by Institutions (%) | 6.42% |
| Float | 205.66M |
Valuation Ratios
The trailing PE ratio is 16.28.
| PE Ratio | 16.28 |
| Forward PE | n/a |
| PS Ratio | 1.99 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | 17.07 |
| P/OCF Ratio | 14.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.55, with an EV/FCF ratio of 8.80.
| EV / Earnings | 8.39 |
| EV / Sales | 1.03 |
| EV / EBITDA | 7.55 |
| EV / EBIT | 13.04 |
| EV / FCF | 8.80 |
Financial Position
The company has a current ratio of 4.26, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.26 |
| Quick Ratio | 3.63 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.11 |
| Interest Coverage | 202.88 |
Financial Efficiency
Return on equity (ROE) is 6.97% and return on invested capital (ROIC) is 8.07%.
| Return on Equity (ROE) | 6.97% |
| Return on Assets (ROA) | 2.24% |
| Return on Invested Capital (ROIC) | 8.07% |
| Return on Capital Employed (ROCE) | 4.25% |
| Weighted Average Cost of Capital (WACC) | 6.03% |
| Revenue Per Employee | 1.11M |
| Profits Per Employee | 135,276 |
| Employee Count | 3,114 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.42 |
Taxes
In the past 12 months, SHA:603367 has paid 70.58 million in taxes.
| Income Tax | 70.58M |
| Effective Tax Rate | 14.22% |
Stock Price Statistics
The stock price has increased by +17.13% in the last 52 weeks. The beta is 0.33, so SHA:603367's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +17.13% |
| 50-Day Moving Average | 16.53 |
| 200-Day Moving Average | 20.05 |
| Relative Strength Index (RSI) | 43.91 |
| Average Volume (20 Days) | 11,345,450 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603367 had revenue of CNY 3.44 billion and earned 421.25 million in profits. Earnings per share was 0.93.
| Revenue | 3.44B |
| Gross Profit | 1.71B |
| Operating Income | 270.96M |
| Pretax Income | 496.19M |
| Net Income | 421.25M |
| EBITDA | 466.28M |
| EBIT | 270.96M |
| Earnings Per Share (EPS) | 0.93 |
Balance Sheet
The company has 3.40 billion in cash and 43.53 million in debt, with a net cash position of 3.36 billion or 7.42 per share.
| Cash & Cash Equivalents | 3.40B |
| Total Debt | 43.53M |
| Net Cash | 3.36B |
| Net Cash Per Share | 7.42 |
| Equity (Book Value) | 6.23B |
| Book Value Per Share | 13.67 |
| Working Capital | 3.99B |
Cash Flow
In the last 12 months, operating cash flow was 466.37 million and capital expenditures -64.76 million, giving a free cash flow of 401.61 million.
| Operating Cash Flow | 466.37M |
| Capital Expenditures | -64.76M |
| Depreciation & Amortization | 195.32M |
| Net Borrowing | -45.90M |
| Free Cash Flow | 401.61M |
| FCF Per Share | 0.89 |
Margins
Gross margin is 49.66%, with operating and profit margins of 7.87% and 12.23%.
| Gross Margin | 49.66% |
| Operating Margin | 7.87% |
| Pretax Margin | 14.40% |
| Profit Margin | 12.23% |
| EBITDA Margin | 13.54% |
| EBIT Margin | 7.87% |
| FCF Margin | 11.66% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 2.08%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 2.08% |
| Dividend Growth (YoY) | -37.80% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 43.42% |
| Buyback Yield | 0.31% |
| Shareholder Yield | 2.39% |
| Earnings Yield | 6.15% |
| FCF Yield | 5.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603367 has an Altman Z-Score of 5.46 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.46 |
| Piotroski F-Score | 5 |